Diltiazem Hydrochloride Capsule, Coated, Extended Release
FDA Label NDC 60687-217

25 label sections · Submitted to the FDA by American Health Packaging · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by American Health Packaging for the product Diltiazem Hydrochloride (NDC 60687-217). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, indications and usage, contraindications, warnings, precautions, general, drug interactions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel – Blister – 120 Mg

Diltiazem
Hydrochloride
Extended-Release
Capsule, USP
(Once-a-Day Dosage)

120 mg

Package/Label Display Panel – Blister – 180 Mg

Diltiazem
Hydrochloride
Extended-Release
Capsule, USP
(Once-a-Day Dosage)

180 mg

Package/Label Display Panel – Blister – 240 Mg

Diltiazem
Hydrochloride
Extended-Release
Capsule, USP
(Once-a-Day Dosage)

240 mg

Package/Label Display Panel – Blister – 300 Mg

Diltiazem
Hydrochloride
Extended-Release
Capsule, USP
(Once-a-Day Dosage)
300 mg

* Please review the disclaimer below.